|
Volumn 41, Issue 1, 2010, Pages
|
'Yes' or 'No' to routine statins after subarachnoid hemorrhage to prevent delayed cerebral ischaemia, vasospasm, and death?: A cautionary tale of 2 meta-analyses
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALTEPLASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
SIMVASTATIN;
ACCURACY;
BLOOD CLOT LYSIS;
BRAIN DEATH;
BRAIN ISCHEMIA;
BRAIN VASOSPASM;
CAROTID ENDARTERECTOMY;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
EDITORIAL;
EVALUATION;
FIBRINOLYTIC THERAPY;
HUMAN;
MEDICAL PRACTICE;
META ANALYSIS;
MORTALITY;
NONHUMAN;
PATIENT CARE;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
RISK REDUCTION;
SENSITIVITY ANALYSIS;
SUBARACHNOID HEMORRHAGE;
BRAIN ISCHEMIA;
HUMANS;
META-ANALYSIS AS TOPIC;
SUBARACHNOID HEMORRHAGE;
VASOSPASM, INTRACRANIAL;
|
EID: 74049158237
PISSN: 00392499
EISSN: None
Source Type: Journal
DOI: 10.1161/STROKEAHA.109.565986 Document Type: Editorial |
Times cited : (8)
|
References (8)
|